Lee Ainslie - Maverick Capital
Holding/activity history for Abcellera Biologics Inc (ABCL)
← All ABCL superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $4.51–8.05 · VW $6.19i | SEC | |
| 2023 Q2 | 48,052 | <0.01 | Reduce 20.83% | <0.01 | $5.53–7.67 · VW $6.86i | $310,416 | SEC |
| 2023 Q1 | 60,691 | 0.01 | Add 119.60% | <0.01 | $7.13–11.38 · VW $9.07i | $457,610 | SEC |
| 2022 Q4 | 27,637 | <0.01 | Add 23.09% | <0.01 | $9.35–14.97 · VW $11.64i | $279,963 | SEC |
| 2022 Q3 | 22,453 | 0.01 | Buy | 0.01 | $9.09–14.50 · VW $11.16i | $222,000 | SEC |